Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pneumothorax.

Michael H Baumann1, Marc Noppen

  • 1Division of Pulmonary and Critical Care Medicine, University of Mississippi Medical Center, Jackson, Mississippi 39216-4505, USA. mbaumann@medicine.umsmed.edu

Respirology (Carlton, Vic.)
|June 9, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis and Biological Evaluation of 4‑Bromo-<i>N,N-</i>dimethyltryptamine (4-Br-DMT): A Synthetic Building Block for Future Analog Development.

ACS omega·2026
Same author

Dual-target mu opioid-dopamine D<sub>3</sub> receptor (MOR-D<sub>3</sub>R) ligands based on etonitazene: New leads for transforming "nitazenes" into novel analgesics.

European journal of medicinal chemistry·2026
Same author

Pharmacokinetics of xylazine and fentanyl in patients presenting to the emergency department after non-fatal opioid overdose.

Drug and alcohol dependence·2026
Same author

Serotonin Transporter Blockade Reduces the Psychedelic-Like Effects of 4-Methoxy-<i>N</i>-methyl-<i>N</i>-isopropyltryptamine and Related Analogs.

ACS chemical neuroscience·2026
Same author

Serotonergic Polypharmacology of 2-Halogenated Tryptamines.

bioRxiv : the preprint server for biology·2026
Same author

Author Correction: A µ-opioid receptor superagonist analgesic with minimal adverse effects.

Nature·2026

Guidelines for managing pneumothorax exist but are underutilized. Treatment varies by type (primary, secondary, traumatic, iatrogenic) and severity, ranging from observation to chest tube placement and pleurodesis to prevent recurrence.

Area of Science:

  • Pulmonary Medicine
  • Thoracic Surgery
  • Critical Care

Background:

  • Spontaneous pneumothorax, categorized as primary or secondary, lacks consistent clinical guideline application.
  • Management strategies for traumatic and iatrogenic pneumothoraces also require clear protocols.

Purpose of the Study:

  • To review current management guidelines for various types of pneumothorax.
  • To highlight discrepancies between guidelines and clinical practice.

Main Methods:

  • Review of existing professional organization guidelines for pneumothorax management.
  • Analysis of treatment approaches for primary, secondary, traumatic, and iatrogenic pneumothoraces.

Main Results:

  • Primary spontaneous pneumothorax: observation for small, asymptomatic cases; aspiration or small catheter for large/symptomatic cases. Recurrence management involves pleurodesis (talc or VATS).

Related Experiment Videos

  • Secondary pneumothorax: chest tube drainage and pleurodesis after the first episode are recommended.
  • Traumatic pneumothorax: typically managed with chest tubes; conservative treatment is an option for some.
  • Iatrogenic pneumothorax: management (observation or small chest tube) depends on patient stability and pneumothorax size, with CT predicting transthoracic needle biopsy complications.

    • Conclusions:

    • There is a need to improve clinician awareness and adherence to established pneumothorax management guidelines.
    • Tailored treatment based on pneumothorax type, size, and patient condition is crucial for optimal outcomes and recurrence prevention.